Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 494
Filter
1.
Curr Vasc Pharmacol ; 20(4): 326-332, 2022.
Article in English | MEDLINE | ID: mdl-35379133

ABSTRACT

Coronavirus disease-2019 (COVID-19) causes mild illness to serious infection with lung involvement, thrombosis, and other complications potentially resulting in fatal outcomes. Recognised inflammatory biomarkers play important roles in managing patients with COVID-19; for example, diagnosis, follow-up, assessment of treatment response, and risk stratification. Inflammatory markers in COVID-19 disease were analysed in two categories. Well-known inflammatory markers include complete blood count, C-reactive protein, albumin, cytokines, and erythrocyte sedimentation rate. Asymmetric dimethylarginine, endocan, pentraxin 3, serum amyloid A, soluble urokinase plasminogen activator receptor, total oxidant status and total antioxidant status, and galectin-3 are considered among the emerging inflammatory markers. This brief narrative review assesses the relationship between these inflammatory markers and COVID-19 infection.


Subject(s)
COVID-19 , Humans , Biomarkers , C-Reactive Protein/metabolism , Cytokines
2.
Angiology ; 73(8): 701-711, 2022 09.
Article in English | MEDLINE | ID: mdl-35476909

ABSTRACT

Non-alcoholic fatty liver disease (NAFLD) is a common disease defined by excess fat deposition in the liver. The course of NAFLD is not fully understood, however, some pathogenic mechanisms have been identified. Accumulation of fat in liver cells is associated with insulin resistance, central obesity, triglyceride accumulation in the liver and hepatic fatty acid metabolism dysregulation that cause steatosis. The other process leads to hepatocyte inflammation and necrosis, which leads to severe hepatic disease; non-alcoholic steatohepatitis. Many clinical studies have underlined the link between NAFLD and atherosclerosis. NAFLD may alter the balance lipid-glucose metabolism as well as increase the risk of hypertension and systemic inflammation. This results in a greater risk of vascular events. The present review considers the link between NAFLD and atherosclerosis.


Subject(s)
Atherosclerosis , Insulin Resistance , Non-alcoholic Fatty Liver Disease , Atherosclerosis/complications , Humans , Inflammation/complications , Insulin Resistance/physiology , Lipid Metabolism/physiology , Non-alcoholic Fatty Liver Disease/complications
3.
Angiology ; 73(8): 772-780, 2022 09.
Article in English | MEDLINE | ID: mdl-35189713

ABSTRACT

Psoriasis vulgaris is associated with an increased risk of atherosclerosis. The C-Reactive Protein-to-Albumin Ratio (CAR) has received increasing attention as an independent prognostic factor for inflammatory diseases. The carotid intima-media thickness (cIMT) is a predictor of atherosclerosis. We assessed the correlation between CAR and cIMT in patients with psoriasis vulgaris. We enrolled 147 participants (72 with psoriasis vulgaris and 75 controls). Disease severity was assessed using the "Psoriasis Area Severity Index (PASI)." Patient and control groups were similar with regard to gender, age, and body mass index (BMI). cIMT was measured in both the left and the right common carotid arteries. CAR values were higher in patients with psoriasis compared with controls (0.93 (0.06-4.32) vs 0.51 (0.10-2.99), p < .001). The patients with psoriasis had a significantly greater cIMT compared with control subjects. (0.53 (0.42-0.65) vs 0.50 (0.41-0.65) mm, p = .03). PASI scores were positively correlated with CAR values (r = 0.532, p < .001). A positive correlation between cIMT and CAR was found in patients with psoriasis vulgaris (r = 0.463, p < .001). CAR is an easily derived reproducible marker that could prove useful for assessing the inflammatory status of patients with psoriasis in clinical practice. CAR may also prove useful as a cardiovascular risk marker in these patients.


Subject(s)
Atherosclerosis , Psoriasis , Atherosclerosis/etiology , Biomarkers , C-Reactive Protein/analysis , Carotid Arteries , Carotid Intima-Media Thickness , Case-Control Studies , Humans , Psoriasis/complications , Risk Factors
5.
Curr Opin Cardiol ; 36(4): 462-468, 2021 07 01.
Article in English | MEDLINE | ID: mdl-33929364

ABSTRACT

PURPOSE OF REVIEW: To consider the role of endocan as an inflammatory marker in cardiovascular diseases. RECENT FINDINGS: Endocan, an endothelial inflammatory marker, is associated with cardiovascular disease. SUMMARY: Vascular endothelial inflammation plays a key role in the pathogenesis of inflammatory and cardiovascular diseases by influencing thrombogenesis, tumour invasion and secretion of bioactive mediators. We discuss the role of endocan mainly in the context of cardiology.


Subject(s)
Cardiovascular Diseases , Proteoglycans , Biomarkers , Cardiovascular Diseases/diagnosis , Endothelium, Vascular , Humans , Neoplasm Proteins
6.
Curr Vasc Pharmacol ; 19(3): 243-249, 2021.
Article in English | MEDLINE | ID: mdl-32316894

ABSTRACT

Vascular diseases are the main reason for morbidity and mortality worldwide. As we know, the earlier phase of vascular diseases is endothelial dysfunction in humans, the endothelial tissues play an important role in inflammation, coagulation, and angiogenesis, via organizing ligand-receptor associations and the various mediators' secretion. We can use many inflammatory non-invasive tests (flowmediated dilatation, epicedial fat thickness, carotid-intima media thickness, arterial stiffness and anklebrachial index) for assessing the endothelial function. In addition, many biomarkers (ischemia modified albumin, pentraxin-3, E-selectin, angiopoietin, endothelial cell specific molecule 1, asymmetrical dimethylarginine, von Willebrand factor, endothelial microparticles and endothelial progenitor cells) can be used to evaluate endothelial dysfunction. We have focused on the relationship between endothelial dysfunction and inflammatory markers of vascular disease in this review.


Subject(s)
Diagnostic Techniques, Cardiovascular , Endothelium, Vascular/metabolism , Inflammation Mediators/metabolism , Vascular Diseases/diagnosis , Animals , Biomarkers/metabolism , Cardiac Imaging Techniques , Endothelium, Vascular/physiopathology , Hemodynamics , Humans , Predictive Value of Tests , Prognosis , Risk Assessment , Risk Factors , Vascular Diseases/metabolism , Vascular Diseases/physiopathology
8.
Angiology ; 71(5): 425-430, 2020 May.
Article in English | MEDLINE | ID: mdl-23359783

ABSTRACT

Atherosclerosis plays an important role in the etiopathogenesis of coronary artery ectasia (CAE). The relationship between total bilirubin (TBil) and carotid intima media thickness (cIMT) in patients with CAE has not been fully investigated. Hence, we evaluated the relationship between TBil levels and cIMT in 142 consecutive eligible patients with CAE, newly diagnosed coronary artery disease (CAD), and normal coronary arteries. There were no significant differences in TBil (P = .772) and cIMT (P = .791) between the CAE and CAD groups. Bilirubin levels were significantly lower in both CAE and CAD groups compared to the controls (P < .01). The cIMT was significantly higher in both CAE and CAD groups compared to control participants (P < .01). A negative correlation between cIMT and TBil was found in all the groups (P < .01, r = .354). We show for the first time that patients with CAE and CAD have lower TBil and greater cIMT compared to controls with normal coronary angiograms.


Subject(s)
Bilirubin/blood , Carotid Intima-Media Thickness , Coronary Artery Disease/blood , Coronary Artery Disease/pathology , Adult , Dilatation, Pathologic/blood , Dilatation, Pathologic/pathology , Female , Humans , Male , Middle Aged
9.
Am J Mens Health ; 13(6): 1557988319893889, 2019.
Article in English | MEDLINE | ID: mdl-31829075

ABSTRACT

Endothelial dysfunction (ED) occurs early in the development of atherosclerosis. Predictors of vascular risk including obesity, hyperlipidemia, metabolic syndrome, diabetes mellitus, and hypertension are associated with both vascular endothelial and ED. Endocan is a novel marker of endothelial dysfunction, inflammation, and atherosclerosis. Raised endocan levels (usually measured by ELISA assays) were reported in some cardiovascular diseases and related conditions. Increased endocan levels may represent the endothelial and inflammatory components of the pathogenesis of ED and may, therefore, prove useful in clinical practice.


Subject(s)
Atherosclerosis/complications , Endothelium, Vascular/metabolism , Erectile Dysfunction/etiology , Neoplasm Proteins/metabolism , Proteoglycans/metabolism , Adult , Atherosclerosis/physiopathology , Biomarkers/metabolism , Endothelium, Vascular/physiopathology , Enzyme-Linked Immunosorbent Assay , Erectile Dysfunction/metabolism , Humans , Male , Middle Aged , Predictive Value of Tests , Risk Assessment
11.
Int J Rheum Dis ; 22(1): 32-37, 2019 Jan.
Article in English | MEDLINE | ID: mdl-27028097

ABSTRACT

BACKGROUND: Cardiovascular diseases, among which atherosclerotic heart disease, are known to be one of the most important mortality and morbidity causes in patients with rheumatoid arthritis (RA). Ischemia modified albumin (IMA) is a potential marker that can be used to assess atherosclerosis-related myocardial ischemia. Another frequently used marker for the assessment of atherosclerotic lesions is the carotid intima media thickness (CIMT). AIM: To evaluate the role that IMA has on atherosclerosis development and its clinical usability in patients with RA, by assessing the values of IMA and CIMT. METHODS AND MATERIALS: Our prospective study was conducted between June 2012 and March 2013 at the Rheumatology Department of Necmettin Erbakan Meram Medical School, Turkey. Fifty-two RA patients, diagnosed according to the 1987 criteria of the American College of Rheumatology, and an age- and sex-matched control group of 46 healthy subjects were included in this study. RESULTS: No significant difference was detected between the groups with respect to age, sex and body mass index. In the patient group the IMA and CIMT values were found to be 0.37 ± 0.12 absorbance units (ABSU) and 0.80 ± 0.22 mm, respectively, while in the control group they were 0.31 ± 0.11 ABSU and 0.51 ± 0.18 mm, respectively. The IMA and CIMT values were significantly higher in the patient group (P = 0.022 and P < 0.0001, respectively). A positive correlation was found between IMA, CIMT and Disease Activity Score of 28 joints (P = 0.016 and P = 0.002, respectively). CONCLUSION: Since the values of IMA were higher in the patient group compared to controls and because of its correlation with CIMT, we suggest the use of IMA as an early marker of atherosclerosis in RA patients.


Subject(s)
Arthritis, Rheumatoid/blood , Carotid Artery Diseases/diagnostic imaging , Carotid Artery, Common/diagnostic imaging , Carotid Intima-Media Thickness , Adult , Arthritis, Rheumatoid/complications , Arthritis, Rheumatoid/diagnosis , Biomarkers/blood , Carotid Artery Diseases/etiology , Case-Control Studies , Early Diagnosis , Female , Humans , Male , Middle Aged , Predictive Value of Tests , Prognosis , Prospective Studies , Risk Factors , Serum Albumin, Human , Turkey , Up-Regulation
14.
Angiology ; 68(5): 381-388, 2017 May.
Article in English | MEDLINE | ID: mdl-27418628

ABSTRACT

The no-reflow (NR) phenomenon represents an acute reduction in coronary blood flow without coronary vessel obstruction, coronary vessel dissection, spasm, or thrombosis. No reflow is an important complication among patients with acute ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI). The complete blood count (CBC) is one of the most frequently ordered laboratory tests in clinical practice. Various studies have evaluated the performance of CBC parameters to predict disease severity and mortality risk. Automated cell counters are routinely available in many clinical laboratories and can be used to determine red blood cell distrubiton width (RDW), platetecrit, platelet count, and and some ratios like the neutrophil-lymphocyte ratio and RDW-platelet ratio. These hematological markers have been reported to be independent predictors of impaired angiographic reperfusion and long-term mortality among patients with STEMI undergoing pPCI. In this context, we reviewed the role of admission CBC parameters for the prediction of NR in patients with STEMI undergoing pPCI.


Subject(s)
Blood Cell Count , No-Reflow Phenomenon/physiopathology , Percutaneous Coronary Intervention , ST Elevation Myocardial Infarction/physiopathology , ST Elevation Myocardial Infarction/surgery , Coronary Angiography , Humans
15.
Angiology ; 68(5): 441-446, 2017 May.
Article in English | MEDLINE | ID: mdl-27494938

ABSTRACT

The prevalence of hypertension is increasing among young population worldwide. So there is an interest in detecting prehypertension and hypertension in childhood. We determined blood pressure (BP) recorded at a screening test in a young population. We retrospectively evaluated the medical records including systolic blood pressure (SBP), diastolic blood pressure (DBP), weight, height, and body mass index (BMI) of 685 male and 130 female apparently healthy adolescents. We evaluated the prevalence of BP categories: normotension, prehypertension, and hypertension. The prevalence of normotension (n = 369), prehypertension (n = 333), and hypertension (n = 113) was 45.3%, 40.9% and 13.9%, respectively; prehypertension and hypertension were significantly higher among males. The prevalence of prehypertension and hypertension was significantly higher among overweight males and females. The BMI significantly correlated with SBP, DBP, and heart rate among both genders. The prevalence of prehypertension and hypertension is high among Turkish adolescents. Screening tests focused on BP and BMI measurement may help detect the young population at risk of hypertension and cardiovascular disease in the future.


Subject(s)
Blood Pressure Determination/methods , Hypertension/diagnosis , Prehypertension/diagnosis , Adolescent , Anthropometry , Echocardiography , Female , Humans , Hypertension/diagnostic imaging , Hypertension/epidemiology , Male , Prehypertension/diagnostic imaging , Prehypertension/epidemiology , Prevalence , Retrospective Studies , Sex Factors , Young Adult
16.
Angiology ; 68(4): 315-321, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27436495

ABSTRACT

Familial Mediterranean fever (FMF) is a disease characterized by chronic inflammation. Atherogenic index of plasma (AIP) is a logarithmic value of the triglyceride to high-density lipoprotein cholesterol ratio and it is a good marker for atherosclerotic heart disease and cardiac risk. In this study, we investigated subclinical atherosclerosis and cardiac risks in patients with FMF. Patients with FMF (78 men and 84 women) and healthy controls (74 men and 82 women) were included in this study. The AIP values of the patients were calculated and carotid intima-media thicknesses (cIMTs) were measured. The cIMT ( P < .001) and AIP ( P < .001) values of patients with FMF were higher than the values of the control group. There was a positive correlation between cIMT and AIP values ( r = .304, P < .001). In regression analysis, we detected an independent relationship between cIMT and AIP (ß = .248, P = .001). Atherogenic index of plasma may be highly correlated with the subclinical atherosclerosis. Particularly, male patients with FMF may have a high cardiac risk.


Subject(s)
Atherosclerosis/blood , Familial Mediterranean Fever/blood , Adult , Biomarkers/blood , Carotid Artery Diseases/blood , Carotid Intima-Media Thickness , Case-Control Studies , Cross-Sectional Studies , Female , Humans , Lipids/blood , Male , Risk Factors , Sex Factors
17.
Clin Appl Thromb Hemost ; 23(6): 663-670, 2017 Sep.
Article in English | MEDLINE | ID: mdl-26907084

ABSTRACT

BACKGROUND: Plasma levels of estimated whole blood viscosity (eWBV) have been increased by endothelial inflammation. Because there were no consistent data for assessing the eWBV levels for prediction of cardiovascular event (CVE) in patients with chronic kidney disease (CKD). We aimed to investigate the relationship between plasma eWBV levels and CVEs in patients with CKD. MATERIALS AND METHODS: We conducted a prospective, cross-sectional, long-term follow-up study, assessing the relationship between plasma eWBV levels and CVE (either fatal or nonfatal) in patients with newly diagnosed CKD. We also evaluated estimated glomerular filtration rate (eGFR), pentraxin 3 (PTX3), high-sensitivity C-reactive protein (hsCRP), and flow-mediated dilatation (FMD). RESULTS: Study patients were divided into 2 groups: patients with CVE and patients without CVE. The eWBV levels were higher in patients with CVE. Additionally, PTX3 and hsCRP were higher, and FMD and eGFR were lower in patients with CVE compared to those without CVE. According to the Cox regression analysis, WBV, plasma asymmetric dimethylarginine levels, FMD, hsCRP, eGFR, systolic blood pressure, calcium, and history of diabetes were independent predictors of CVEs in patients with CKD. Kaplan Meier survival curves were generated to establish the impact of the WBV on the cumulative survival of the cohort. Patients with eWBV values higher than 5.2 centipoise (cP) had lower survival rates when compared to patients with eWBV values lower than 5.2 cP (log rank = 4.49 df = 1 P = .034). CONCLUSION: In conclusion, plasma eWBV levels may increase the presence of lower eGFR and affect CVE in patients with CKD independent of classical and unconventional risk factors.


Subject(s)
Blood Viscosity , Cardiovascular Diseases/blood , Renal Insufficiency, Chronic/complications , Adult , Cross-Sectional Studies , Female , Follow-Up Studies , Glomerular Filtration Rate , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Prospective Studies , Renal Insufficiency, Chronic/blood , Risk Factors
20.
Prz Gastroenterol ; 11(3): 200-205, 2016.
Article in English | MEDLINE | ID: mdl-27713783

ABSTRACT

INTRODUCTION: Chronic hepatitis C (CHC) infection is a systemic disorder that can lead to liver inflammation, fibrosis, cirrhosis, and hepatocellular cancer. The mean platelet volume (MPV) is widely used as an inflammatory marker to evaluate the platelet function and the status of systemic inflammation. AIM: To determine the pre- and post-treatment MPV values in CHC patients who were administered a 48-week antiviral therapy based on systemic inflammation. MATERIAL AND METHODS: We enrolled 28 patients, diagnosed with CHC genotype 1b, who received a 48-week antiviral therapy and attended regular follow-up, and 28 healthy individuals. In diagnosing CHC, a positive anti-HCV for a minimum duration of 6 months and a positive serum HCV RNA were accepted as the criteria. The patients were assigned to one of two groups based on their group 1 (pre-treatment values) and group 2 (post-treatment values) after 3 months therapy. We analysed and compared the blood samples of all of the groups. RESULTS: The MPV value was 8.89 ±1.20 in group 1 and 8.00 ±1.07 in group 2, and 8.21 ±1.18 in the control group. The value in group 1 was detected to be statistically significantly different from that in group 2 and the control group (p < 0.0001, p = 0.045, respectively). No statistically significant difference was observed between group 2 and the control group (p = 0.455). CONCLUSIONS: The results of this study suggest that MPV could represent an inexpensive marker for use in assessing low-grade inflammation in patients with CHC.

SELECTION OF CITATIONS
SEARCH DETAIL